ArticleAllergy & rhinology (Providence, R.I.)2017

Long-term omalizumab use in the treatment of exercise-induced anaphylaxis.

Mark R Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.